Under pressure: tackling hypertension as a pillar of preventive cardiology
-
By
-
Gal Tsaban
-
Victor Aboyans
-
October 10, 2025
-
0 min
Addressing Hypertension: Insights from Recent Preventive Cardiology Studies
Overview
Recent studies highlight the importance of cumulative blood pressure exposure, folate status, dietary flavan-3-ols, and central blood pressure thresholds in hypertension management. Intensive systolic blood pressure control improves cardiovascular outcomes even in patients with worsening renal function, while hydration biomarkers may predict hypertension and heart failure risk.
Background
Hypertension remains a critical risk factor for cardiovascular disease worldwide. Traditional single-point blood pressure measurements may underestimate risk, emphasizing the need for cumulative exposure assessment. Nutritional factors such as folate deficiency and dietary components like flavan-3-ols have emerged as modifiable contributors to blood pressure regulation. Additionally, novel diagnostic thresholds for central blood pressure and large-scale exposome-wide analyses are expanding understanding of hypertension risk factors.
Data Highlights
| Study | Population | Key Findings |
|---|---|---|
| Masrouri et al. (MESA study) | 3000+ adults | Higher cumulative systolic BP linked to increased LV mass, impaired myocardial strain, and myocardial scarring |
| Zhang et al. | UK Biobank | Folate deficiency associated with increased hypertension risk; Mendelian randomization supports causality |
| Lagou et al. | 5205 participants, 145 RCTs | Flavan-3-ols modestly reduce office and ambulatory BP; improve endothelial function |
| Wang et al. | 34,000+ UK Biobank participants | Central SBP threshold of 135 mmHg predicts cardiovascular risk beyond brachial BP |
| Yang et al. | 214,000+ UK Biobank participants | 964 risk factor associations with incident hypertension identified; 146 supported genetically |
| Xu et al. (SPRINT trial) | Intensive BP control group | Intensive systolic BP <120 mmHg reduces CV events and mortality even with worsening renal function |
| Rabinowitz et al. | 407,000+ adults, 20 years | Serum sodium >140 mmol/L and tonicity >287 mOsmol/kg linked to higher hypertension and heart failure risk |
Key Findings
- Cumulative systolic blood pressure exposure correlates with adverse cardiac remodeling and function beyond single measurements.
- Folate deficiency causally increases hypertension risk, suggesting nutritional intervention potential.
- Dietary flavan-3-ols produce modest blood pressure reductions and improve endothelial function with minimal adverse effects.
- Central systolic blood pressure threshold of 135 mmHg enhances cardiovascular risk stratification beyond brachial measurements.
- Intensive systolic blood pressure control (<120 mmHg) significantly lowers cardiovascular events and mortality, including in patients with worsening renal function.
- High-normal serum sodium and plasma tonicity levels are associated with increased risks of hypertension and heart failure, indicating potential early biomarkers.
Clinical Implications
Monitoring cumulative blood pressure exposure may improve cardiovascular risk assessment compared to isolated readings. Ensuring adequate folate intake and incorporating flavan-3-ol-rich foods could serve as preventive strategies for hypertension. Intensive blood pressure control targets should be considered even in patients with renal function decline, while assessment of central blood pressure and hydration biomarkers may refine risk stratification and guide early intervention.
Conclusion
Emerging evidence underscores the multifaceted nature of hypertension risk and management, highlighting the value of cumulative exposure assessment, nutritional factors, and intensive blood pressure control. Integrating these insights can enhance preventive cardiology approaches and improve patient outcomes.
References
- Masrouri et al. 2024 -- Cumulative blood pressure exposure and cardiac structure and function
- Zhang et al. 2024 -- Association between folate deficiency and hypertension
- Lagou et al. 2024 -- Impact of flavan-3-ols on blood pressure and endothelial function
- Wang et al. 2024 -- Diagnostic threshold for central blood pressure
- Yang et al. 2024 -- Risk factors associated with incident hypertension
- Xu et al. 2024 -- Intensive systolic blood pressure control and renal function
- Rabinowitz et al. 2024 -- Serum sodium, tonicity, and cardiovascular risk
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
